How can small biopharma use end-to-end CDMO partnerships to accelerate development?

Published on July 3, 2024

There is growing evidence that pharma and biotech companies in general, and small biopharmas in particular, are increasingly looking at ‘end-to-end’ partnerships with contract development and manufacturing organizations (CDMOs) for the outsourcing of drug development. It is also clear that a growing number of CDMOs are adding to their range of capabilities in order to […]